Characteristics of the Four Subtypes of Myelodysplastic/Myeloproliferative Neoplasms

Experimental and Therapeutic Medicine - Greece
doi 10.3892/etm.2013.975
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Effective Treatment of Low-Dose Decitabine in Myelodysplastic Syndrome/Myeloproliferative Neoplasms

OncoTargets and Therapy
OncologyPharmacology
2017English

Routine Blood Examinations Combined With Morphological Analysis for the Diagnosis of Myelodysplastic/Myeloproliferative Neoplasms

Oncology Letters
Cancer ResearchOncology
2016English

Allogeneic Hematopoietic Cell Transplantation (HCT) Outcomes in Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)

Biology of Blood and Marrow Transplantation
TransplantationHematology
2014English

Histological Evaluation of Myeloproliferative Neoplasms

Journal of clinical and experimental hematopathology : JCEH
Medicine
2018English

Genetic Complexity of Myeloproliferative Neoplasms

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2008English

New Classification for Myeloproliferative Neoplasms

Cancer Discovery
Oncology
2018English

Mutations of ASXL1 Gene in Myeloproliferative Neoplasms

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2009English

Italian Survey on Clinical Practice in Myeloproliferative Neoplasms. A GIMEMA Myeloproliferative Neoplasms Working Party Initiative

American Journal of Hematology
Hematology
2019English

DNMT3A Mutations in Myeloproliferative Neoplasms

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy